-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Changchun Hi-Tech announced that its holding subsidiary Jinsai Pharmaceuticals Leuprolide Injection Emulsion has recently received a drug clinical trial approval notice from NMPA
.
According to the "Drug Administration Law of the People's Republic of China" and relevant regulations, after review, the leuprolide injection emulsion accepted on December 30, 2021 meets the relevant requirements for drug registration, and the clinical trial application is approved, namely: an evaluation A clinical study of the safety and efficacy of prorelin injection emulsion in the treatment of advanced prostate cancer
.